找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

Titlebook: RNA Vaccines; Methods and Protocol Thomas Kramps Book 2024Latest edition The Editor(s) (if applicable) and The Author(s), under exclusive l

[复制链接]
楼主: Encomium
发表于 2025-3-23 13:23:31 | 显示全部楼层
Self-Replicating RNA Derived from the Genomes of Positive-Strand RNA Virusesd approaches to novel safe and effective vaccines. The following chapter summarizes the principles how such RNAs can be established and used for design of vaccines. Due to the large variety of strategies needed to circumvent specific pitfalls in the design of such constructs the technical details of
发表于 2025-3-23 16:11:13 | 显示全部楼层
发表于 2025-3-23 19:28:30 | 显示全部楼层
发表于 2025-3-24 00:58:49 | 显示全部楼层
发表于 2025-3-24 03:02:02 | 显示全部楼层
Generation and Characterization of In Vitro Transcribed mRNA. We then describe methods used for mRNA characterization, including UV and fluorescence spectrophotometry, as well as gel electrophoresis. Moreover, characterization of the in vitro transcribed RNA using the Bioanalyzer instrument is described, allowing a higher resolution analysis of the target mo
发表于 2025-3-24 06:59:09 | 显示全部楼层
发表于 2025-3-24 11:34:20 | 显示全部楼层
Sequence-Optimized mRNA Vaccines Against Infectious Disease a specific panel of techniques for production and testing. Here, we describe the production of stabilized mRNA vaccines (RNActive. technology) with enhanced immunogenicity, generated using conventional nucleotides only, by introducing changes to the mRNA sequence and by formulation into lipid nanop
发表于 2025-3-24 15:22:36 | 显示全部楼层
发表于 2025-3-24 20:06:53 | 显示全部楼层
Electroporation of mRNA as a Universal Technology Platform to Transfect a Variety of Primary Cells wtypes. We have spent more than two decades to optimize and adapt this method, first for antigen-loading of dendritic cells (DCs) and subsequently for T cells, B cells, bulk PBMCs, and several cell lines. In this regard, antigens were introduced, processed, and presented in context of MHC class I and
发表于 2025-3-25 02:13:10 | 显示全部楼层
A Basic Method for Formulating mRNA-Lipid Nanoparticle Vaccines in the Labn in 2018, and of the two mRNA SARS-CoV-2 vaccines, BNT162b2 and mRNA-1273 in 2021. A key to the success of these therapeutics lies in the lipid-based delivery system. The therapeutic RNAs are encapsulated in lipid nanoparticles (LNPs), which protect against enzymatic degradation and efficiently del
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-5-14 13:32
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
快速回复 返回顶部 返回列表